HIPO Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
132.4M
-8.5%
144.7M
+26.0%
114.8M
-25.2%
153.4M
+49.2%
102.8M
Cost of Revenue
-15600000
0
0
-100.0%
39.6M
+477.1%
-10500000
Gross Profit
148.0M
+2.3%
144.7M
+26.0%
114.8M
+0.9%
113.8M
+0.4%
113.3M
Operating Expenses
106.6M
-19.9%
133.1M
+67.6%
79.4M
+1.9%
77.9M
-7.0%
83.8M
R&D
11.0M
+8.9%
10.1M
+7.4%
9.4M
+13.3%
8.3M
+3.8%
8.0M
SG&A
22.9M
-6.5%
24.5M
+8.9%
22.5M
-6.6%
24.1M
-1.6%
24.5M
Operating Income
41.4M
+256.9%
11.6M
-67.2%
35.4M
-1.4%
35.9M
+21.7%
29.5M
EBITDA
41.4M
+256.9%
11.6M
-67.2%
35.4M
-37.1%
56.3M
+69.1%
33.3M
Net Income
8.8M
-12.9%
10.1M
+42.3%
7.1M
+18.3%
6.0M
-93.9%
98.1M
EPS (Basic)
$0.33
-13.2%
$0.38
+40.7%
$0.27
+12.5%
$0.24
-93.8%
$3.90
EPS (Diluted)
$0.33
-13.2%
$0.38
+40.7%
$0.27
+22.7%
$0.22
-94.2%
$3.77
Shares (Diluted)
27.0M
+1.8%
26.6M
+0.8%
26.4M
-2.5%
27.0M
+3.8%
26.0M
Hippo (HIPO) — Financials